C. Tyrrell

2.0k citations

49 papers · 1.5k indexed · h-index 18

Impact in

Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Endocrinology, Diabetes and Metabolism top 5%
- Hormonal and reproductive studies

Papers in ⓘ

Pulmonary and Respiratory Medicine 33
- Prostate Cancer Treatment and Research 28
- Prostate Cancer Diagnosis and Treatment 12
Endocrinology, Diabetes and Metabolism 9
- Hormonal and reproductive studies 9

Co-authors: Peter Iversen (10 shared papers)Teuvo L.J. Tammela (8 shared papers)Kevin Carroll (7 shared papers)Amir V. Kaisary (5 shared papers)John Anderson (4 shared papers)M. C. Chamberlain (3 shared papers)Hendrik Van Poppel (3 shared papers)William A. See (5 shared papers)
Journals: The Journal of Urology (5 papers)The Breast (4 papers)Urology (4 papers)European Urology (4 papers)Cancer (2 papers)
Partner nations: United Kingdom United States Denmark

In The Last Decade

C. Tyrrell

49 papers receiving 1.4k citations

Peers

Countries citing papers authored by C. Tyrrell

Since Specialization

Citations

This map shows the geographic impact of C. Tyrrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tyrrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tyrrell more than expected).

Fields of papers citing papers by C. Tyrrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Tyrrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tyrrell. The network helps show where C. Tyrrell may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Tyrrell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Tyrrell Line = papers co-authored together C. Tyrrell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP The Journal of Urology ·Peter Iversen, C. Tyrrell, Amir V. Kaisary, John Anderson, Hendrik Van Poppel, Teuvo L.J. Tammela, M. C. Chamberlain, Kevin Carroll, I. Melezínek	2000	265
2	A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer * European Journal of Cancer ·W. Jonat, Anthony Howell, Carl Blomqvist, W. Eiermann, Gerard Winblad, C. Tyrrell, L. Mauriac, Henri Roché, Steinar Lundgren, Richard Hellmund, M. Azab	1996	207
3	Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program The Journal of Urology ·William A. See, Manfred P. Wirth, David G. McLeod, Peter Iversen, Ira Klimberg, Donald M. Gleason, Gerald W. Chodak, James E. Montie, C. Tyrrell, D. M. A. WALLACE, K.P.J. Delaere, Sigmund Vaage, Teuvo L.J. Tammela, O Lukkarinen, Bo‐Eric Persson, Kevin Carroll, Geert J.C.M. Kolvenbag	2002	175
4	Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years Urology ·Peter Iversen, C. Tyrrell, Amir V. Kaisary, John Anderson, Luc Baert, Teuvo L.J. Tammela, M. C. Chamberlain, Kevin Carroll, Karen Gotting-Smith, G. Blackledge	1998	125
5	A Multicenter Randomized Trial Comparing the Luteinizing Hormone-Releasing Hormone Analogue Goserelin Acetate Alone and with Flutamide in the Treatment of Advanced Prostate Cancer The Journal of Urology ·C. Tyrrell, J. E. Altwein, F. Klippel, Eberhard Varenhorst, G. Lunglmayr, Francesco Boccardo, I.M. Holdaway, Jacques‐Antoine Haefliger, J. P. Jordaan, (unknown), (unknown)	1991	80
6	Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression Urology ·Manfred P. Wirth, C. Tyrrell, Michael B. Wallace, K.P.J. Delaere, Manuel Sánchez‐Chapado, J. Ramon, John Hetherington, Francisco Pina, C.F. Heynes, Torsten Börchers, Thomas Morris, A Stone	2001	57
7	The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer Journal of Cancer Research and Clinical Oncology ·William A. See, C. Tyrrell, (unknown)	2006	53
8	The Response of Lymph Node Metastases of Testicular Teratoma to Radiation Therapy British Journal of Urology ·C. Tyrrell, Michael Peckham	1976	53
9	Bicalutamide (‘Casodex’) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme Radiotherapy and Oncology ·C. Tyrrell, H. Payne, William A. See, David G. McLeod, Manfred P. Wirth, Peter Iversen, J. Armstrong, Clive Morris	2005	50
10	Casodex<sup>TM</sup> 10–200 mg Daily, Used as Monotherapy for the Treatment of Patients with Advanced Prostate Cancer European Urology ·C. Tyrrell, L. Denis, D.W.W. Newling, Mark S. Soloway, KS Channer, I. D. Cockshott, on behalf of the lsquo Casodex rsquo Study Group	1998	48
11	Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate Urology ·F. Debruyne, Robin Murray, Yves Fradet, Jan Johansson, C. Tyrrell, Francesco Boccardo, Louis Denis, J. Marberger, Daniel Brüne, Jens Rassweiler, Tony Vangeneugden, J. Bruynseels, Monique Janssens, Peter De Porre	1998	42
12	Efficacy and Tolerability of Radiotherapy as Treatment for Bicalutamide-induced Gynaecomastia and Breast Pain in Prostate Cancer European Urology ·Hendrik Van Poppel, C. Tyrrell, Karin Haustermans, P. Van Cangh, F. Keuppens, P Colombeau, Thomas Morris, Louise Garside	2004	40
13	Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration British Journal of Urology ·C. Tyrrell, Peter Iversen, Teuvo L.J. Tammela, John Anderson, Thomas Björk, Amir V. Kaisary, Thomas Morris	2006	27
14	Radium-223 in the treatment of metastatic hormone refractory prostate cancer (HRPC): Results from a randomized, placebo-controlled, phase II study Journal of Clinical Oncology ·Stefan Nilsson, Lars Franzén, C. Tyrrell, R J Blom, Jan Tennvall, Bo Lennernäs, Dag Clement Johannessen, M. Sokal, Chris Parker, Ove Bruland	2007	24
15	Multicenter randomized trial comparing zoladex with zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update Cancer ·C. Tyrrell, J. E. Altwein, F. Klippel, Eberhard Varenhorst, G. Lunglmayr, Francesco Boccardo, I.M. Holdaway, Jacques‐Antoine Haefliger, J. P. Jordaan, M. Sotarauta, (unknown)	1993	23
16	Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up Prostate Cancer and Prostatic Diseases ·Manfred P. Wirth, C. Tyrrell, K.P.J. Delaere, Manuel Sánchez‐Chapado, J. Ramon, D. Michael A. Wallace, John Hetherington, Francisco Pina, Chris Heyns, Sunil Navani, J. Armstrong, (unknown)	2006	22
17	Casodex: A pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancer The Prostate ·C. Tyrrell	1992	20
18	Tolerability and Quality of LifeAspects with the Anti-AndrogenCasodex (IC1176,334) asMonotherapy for Prostate Cancer European Urology ·C. Tyrrell	1994	17
19	Intravenous pamidronate: infusion rate and safety. PubMed ·C. Tyrrell, Michelle Collinson, E L Madsen, J. Ford, Thomas Coleman	1994	17
20	The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours Clinical Radiology ·C. Tyrrell, David O. Cosgrove, V. R. McCready, Michael Peckham	1977	16

About C. Tyrrell

C. Tyrrell is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Estrogen and related hormone effects (10 papers), Hormonal and reproductive studies (9 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Bone health and treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Endocrinology, Diabetes and Metabolism (415 citations), Cancer Research (277 citations), Oncology (322 citations) and Genetics (303 citations). C. Tyrrell has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Peter Iversen, Teuvo L.J. Tammela, Kevin Carroll, Amir V. Kaisary, John Anderson, M. C. Chamberlain, Hendrik Van Poppel, William A. See, I. Melezínek and Michael Peckham. Their work appears in journals such as The Journal of Urology, The Breast, Urology, European Urology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact